Amdocs (NASDAQ:DOX) Announces Earnings Results, Misses Expectations By $0.19 EPS

Amdocs (NASDAQ:DOX - Get Free Report) issued its earnings results on Tuesday. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by ($0.19), Zacks reports. Amdocs had a return on equity of 18.89% and a net margin of 10.19%. Amdocs updated its Q2 2025 guidance to 1.670-1.730 EPS and its FY 2025 guidance to 6.859-7.116 EPS.

Amdocs Trading Up 0.0 %

DOX traded up $0.01 during trading hours on Friday, reaching $85.97. 671,265 shares of the company's stock traded hands, compared to its average volume of 632,452. The firm has a 50-day moving average price of $85.94 and a 200 day moving average price of $86.43. The firm has a market capitalization of $9.71 billion, a PE ratio of 19.95, a PEG ratio of 1.41 and a beta of 0.71. The company has a quick ratio of 1.20, a current ratio of 1.16 and a debt-to-equity ratio of 0.22. Amdocs has a 52-week low of $74.41 and a 52-week high of $94.04.

Amdocs Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Sunday, April 20th. Stockholders of record on Monday, March 31st will be issued a $0.527 dividend. This represents a $2.11 annualized dividend and a dividend yield of 2.45%. This is an increase from Amdocs's previous quarterly dividend of $0.48. The ex-dividend date is Monday, March 31st. Amdocs's dividend payout ratio is presently 44.55%.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on DOX. StockNews.com raised shares of Amdocs from a "buy" rating to a "strong-buy" rating in a report on Wednesday. Barclays decreased their target price on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a research report on Thursday, November 14th. Finally, Oppenheimer lifted their price target on Amdocs from $98.00 to $105.00 and gave the stock an "outperform" rating in a research report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Amdocs presently has an average rating of "Buy" and an average target price of $101.20.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.